Javier Lara García

Dr. Javier Lara García


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Boletín del Colegio Mexicano de Urología
Verified
Journal Article
Open access
PDF file
TRTania G. Rodríguez-Arciniega
Tania G. Rodríguez-Arciniega
JAJorge Adrian Ramirez de Arellano
Jorge Adrian Ramirez de Arellano
JGJavier Lara García
Javier Lara García
RRRoberto Rojas-Castillo
Roberto Rojas-Castillo
GOGabriel Ochoa-Cabral
Gabriel Ochoa-Cabral
ESERICK SIERRA-DIAZ
ERICK SIERRA-DIAZ
Background: Acute kidney injury (AKI) related to intravenous (IV) contrast media exposure is a global concern since induced nephrotoxicity is among the main causes of AKI in hospitalized patients after medical procedures such as enhanced computed tomography (CT) scans and percutaneous vascular interventions. This research aims to determine the frequency of AKI after IV contrast media exposure. Methods: A prospective cohort including 273 patients divided into four groups was performed. Groups I-III were exposed to IV contrast media. Serum creatinine was measured before and after procedures, and the glomerular filtration rate (GFR) was calculated. Univariate, bivariate, and multivariate statistics were used to calculate mean differences and AKI-related risk factors. Results: Only group one [percutaneous coronary intervention (PCI)] showed statistical changes in GFR after contrast media exposure, and 11.4% of patients in this group developed AKI. No significant differences were observed in the other groups. Multivariate analysis showed no relation between gender, anthropometric characteristics, and comorbidities with AKI development after IV contrast media exposure. Conclusion: Results reported in the present study showed that IV contrast media exposure has no significant changes in GFR after enhanced CT scans. However, after PCI, significant changes in GFR were observed (p < 0.05), including AKI in some patients.

10 January 2025 in Journal of Imaging
Verified
Journal Article
Open access
PDF file
JGJavier Lara García
Javier Lara García
JRJessica Romo-Martínez
Jessica Romo-Martínez
JDJonathan Javier De-La-Cruz-Cisneros
Jonathan Javier De-La-Cruz-Cisneros
MOMarco Antonio Olvera
Marco Antonio Olvera
LMLuis Jesús Márquez-Bejarano
Luis Jesús Márquez-Bejarano
The area postrema (AP) is a key circumventricular organ involved in the regulation of autonomic functions. Accurate identification of the AP via MRI is essential in neuroimaging but it is challenging. This study evaluated 3D FSE Cube T2WI, 3D FSE Cube FLAIR, and 3D DIR sequences to improve AP detection in patients with and without multiple sclerosis (MS). A case–control study included 35 patients with MS and 35 with other non-demyelinating central nervous system diseases (ND-CNSD). MRI images were acquired employing 3D DIR, 3D FSE Cube FLAIR, and 3D FSE Cube T2WI sequences. The evaluation of AP was conducted using a 3-point scale. Statistical analysis was performed with the chi-square test used to assess group homogeneity and differences between sequences. No significant differences were found in the visualization of the AP between the MS and ND-CNSD groups across the sequences or planes. The AP was not visible in 27.6% of the 3D FSE Cube T2WI sequences, while it was visualized in 99% of the 3D FSE Cube FLAIR sequences and 100% of the 3D DIR sequences. The 3D DIR sequence showed superior performance in identifying the AP.